Louise Lidemalm

Artiklar

Article: EBIOMEDICINE. 2024;103:105124

The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ γ

Li X; Hernandez I; Koyuncu S; Haeggblad M; Lidemalm L; Abbas AA; Bendeguz S; Goebloes A; Brautigam L; Lucas JJ; Carreras-Puigvert J; Huehn D; Pircs K; Vilchez D; Fernandez-Capetillo O
Article: FEBS OPEN BIO. 2022;12(10):1896-1908

New regulators of the tetracycline-inducible gene expression system identified by chemical and genetic screens

Colicchia V; Haggblad M; Sirozh O; Porebski B; Balan M; Li X; Lidemalm L; Carreras-Puigvert J; Huhn D; Fernandez-Capetillo O
Article: MOLECULAR ONCOLOGY. 2022;16(1):148-165

Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells

Huhn D; Marti-Rodrigo P; Mouron S; Hansel C; Tschapalda K; Porebski B; Haggblad M; Lidemalm L; Quintela-Fandino M; Carreras-Puigvert J; Fernandez-Capetillo O
Article: CELL CHEMICAL BIOLOGY. 2019;26(2):235-243.e5

A Chemical Screen Identifies Compounds Limiting the Toxicity of C9ORF72 Dipeptide Repeats

Corman A; Jung B; Haggblad M; Brautigam L; Lafarga V; Lidemalm L; Huhn D; Carreras-Puigvert J; Fernandez-Capetillo O
Article: INFECTION ECOLOGY & EPIDEMIOLOGY. 2018;8(1):1528117

Baseline dasabuvir resistance in Hepatitis C virus from the genotypes 1, 2 and 3 and modeling of the NS5B-dasabuvir complex by the in silico approach.

Akaberi D; Bergfors A; Kjellin M; Kameli N; Lidemalm L; Kolli B; Shafer RW; Palanisamy N; Lennerstrand J